Condor Capital Management cut its stake in shares of Danaher Corporation (NYSE:DHR) by 1.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 18,871 shares of the conglomerate’s stock after selling 297 shares during the period. Condor Capital Management’s holdings in Danaher Corporation were worth $1,593,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in DHR. Waldron LP acquired a new stake in shares of Danaher Corporation during the first quarter valued at about $320,000. Empire Life Investments Inc. increased its position in shares of Danaher Corporation by 2.3% during the first quarter. Empire Life Investments Inc. now owns 77,900 shares of the conglomerate’s stock valued at $6,662,000 after acquiring an additional 1,764 shares during the last quarter. HPM Partners LLC increased its position in shares of Danaher Corporation by 178.9% during the first quarter. HPM Partners LLC now owns 75,323 shares of the conglomerate’s stock valued at $6,442,000 after acquiring an additional 48,312 shares during the last quarter. Checchi Capital Advisers LLC increased its position in shares of Danaher Corporation by 9.0% during the first quarter. Checchi Capital Advisers LLC now owns 6,348 shares of the conglomerate’s stock valued at $543,000 after acquiring an additional 526 shares during the last quarter. Finally, Davis R M Inc. increased its position in shares of Danaher Corporation by 1.0% during the first quarter. Davis R M Inc. now owns 395,701 shares of the conglomerate’s stock valued at $33,844,000 after acquiring an additional 4,095 shares during the last quarter. Institutional investors and hedge funds own 75.68% of the company’s stock.

Shares of Danaher Corporation (NYSE:DHR) opened at 87.63 on Friday. The firm’s 50-day moving average is $85.07 and its 200-day moving average is $84.19. Danaher Corporation has a 12-month low of $75.71 and a 12-month high of $88.62. The firm has a market cap of $60.88 billion, a PE ratio of 27.97 and a beta of 1.03.

Danaher Corporation (NYSE:DHR) last released its earnings results on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.97 by $0.02. The company had revenue of $4.51 billion during the quarter, compared to analysts’ expectations of $4.50 billion. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The business’s revenue was up 6.3% on a year-over-year basis. During the same period in the prior year, the business posted $0.90 EPS. Equities analysts expect that Danaher Corporation will post $3.95 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 29th will be paid a dividend of $0.14 per share. This represents a $0.56 annualized dividend and a dividend yield of 0.64%. The ex-dividend date is Thursday, September 28th. Danaher Corporation’s dividend payout ratio (DPR) is currently 17.83%.

Several research firms have recently commented on DHR. Morgan Stanley reissued an “overweight” rating and issued a $95.00 price objective (up previously from $86.00) on shares of Danaher Corporation in a research note on Friday. Zacks Investment Research raised shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 price objective for the company in a research note on Thursday. Cowen and Company reissued a “buy” rating and issued a $90.00 price objective on shares of Danaher Corporation in a research note on Wednesday. Goldman Sachs Group, Inc. (The) reissued a “neutral” rating and issued a $83.00 price objective on shares of Danaher Corporation in a research note on Tuesday, September 26th. Finally, J P Morgan Chase & Co reissued an “overweight” rating and issued a $95.00 price objective on shares of Danaher Corporation in a research note on Friday, September 8th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the stock. Danaher Corporation presently has a consensus rating of “Buy” and an average price target of $92.62.

ILLEGAL ACTIVITY WARNING: “Danaher Corporation (DHR) Holdings Decreased by Condor Capital Management” was first posted by Watch List News and is the property of of Watch List News. If you are reading this story on another domain, it was illegally stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at https://www.watchlistnews.com/danaher-corporation-dhr-holdings-decreased-by-condor-capital-management/1616871.html.

In other news, Director Linda P. Hefner sold 10,578 shares of the stock in a transaction that occurred on Friday, July 21st. The stock was sold at an average price of $83.03, for a total transaction of $878,291.34. Following the completion of the transaction, the director now directly owns 42,151 shares in the company, valued at approximately $3,499,797.53. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider William King sold 7,458 shares of the stock in a transaction that occurred on Friday, July 21st. The shares were sold at an average price of $82.97, for a total value of $618,790.26. Following the transaction, the insider now owns 18,245 shares of the company’s stock, valued at $1,513,787.65. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 71,496 shares of company stock valued at $5,916,223. Company insiders own 12.20% of the company’s stock.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.